• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Opinion

Video

Comparative Analysis: Deucravacitinib and Adalimumab in Psoriasis Treatment

Author(s):

Alexa Hetzel, MS, PA-C,Andrew Mastro, MS, PA-C

Medical professionals discuss ongoing clinical trials and novel medications for the treatment of psoriasis.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Reviewing Complex Cases: Concomitant PsO and PsA
January 28th 2025

Reviewing Complex Cases: Concomitant PsO and PsA

The Cutaneous Connection: An Inside Look of the Inclusive Atlas
November 4th 2021

The Cutaneous Connection: An Inside Look of the Inclusive Atlas

Clinical Validation Reached in Phase 2a Trial of AX-158 for Psoriasis
January 22nd 2025

Clinical Validation Reached in Phase 2a Trial of AX-158 for Psoriasis

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
September 23rd 2021

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

Secukinumab Demonstrates Long-Term Safety and Efficacy in Pediatric Patients with GPP
January 20th 2025

Secukinumab Demonstrates Long-Term Safety and Efficacy in Pediatric Patients with GPP

UCB Launches 320mg Single-Injection Bimekizumab
January 16th 2025

UCB Launches 320mg Single-Injection Bimekizumab

© 2025 MJH Life Sciences

All rights reserved.